161 related articles for article (PubMed ID: 16489098)
21. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer.
Cox DG; Pontes C; Guino E; Navarro M; Osorio A; Canzian F; Moreno V;
Br J Cancer; 2004 Jul; 91(2):339-43. PubMed ID: 15173859
[TBL] [Abstract][Full Text] [Related]
22. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
23. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
[TBL] [Abstract][Full Text] [Related]
24. A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients.
Clar H; Langsenlehner U; Krippl P; Renner W; Leithner A; Gruber G; Hofmann G; Yazdani-Biuki B; Langsenlehner T; Windhager R
Breast Cancer Res Treat; 2008 Oct; 111(3):449-52. PubMed ID: 17978878
[TBL] [Abstract][Full Text] [Related]
25. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India.
Gangwar R; Mandhani A; Mittal RD
Surgery; 2011 Jan; 149(1):126-34. PubMed ID: 20627335
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case-control study.
Fawzy MS; Aly NM; Shalaby SM; El-Sawy WH; Abdul-Maksoud RS
Gene; 2013 Sep; 527(2):601-5. PubMed ID: 23792017
[TBL] [Abstract][Full Text] [Related]
27. The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
Skarke C; Reus M; Schmidt R; Grundei I; Schuss P; Geisslinger G; Lötsch J
Clin Pharmacol Ther; 2006 Dec; 80(6):621-32. PubMed ID: 17178263
[TBL] [Abstract][Full Text] [Related]
28. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
[TBL] [Abstract][Full Text] [Related]
29. Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer.
Romanowicz-Makowska H; Smolarz B; Kulig A
Pol J Pathol; 2005; 56(4):161-5. PubMed ID: 16477874
[TBL] [Abstract][Full Text] [Related]
30. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
[TBL] [Abstract][Full Text] [Related]
31. An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer.
Bu D; Tomlinson G; Lewis CM; Zhang C; Kildebeck E; Euhus DM
Breast Cancer Res Treat; 2006 Oct; 99(3):257-65. PubMed ID: 16596326
[TBL] [Abstract][Full Text] [Related]
32. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
Long JR; Egan KM; Dunning L; Shu XO; Cai Q; Cai H; Dai Q; Holtzman J; Gao YT; Zheng W
Pharmacogenet Genomics; 2006 Apr; 16(4):237-43. PubMed ID: 16538170
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 Gene-765 single nucleotide polymorphism as a protective factor against periodontitis in Taiwanese.
Ho YP; Lin YC; Yang YH; Ho KY; Wu YM; Tsai CC
J Clin Periodontol; 2008 Jan; 35(1):1-8. PubMed ID: 18173398
[TBL] [Abstract][Full Text] [Related]
34. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese.
Ma SL; Tang NL; Zhang YP; Ji LD; Tam CW; Lui VW; Chiu HF; Lam LC
Neurobiol Aging; 2008 Jun; 29(6):856-60. PubMed ID: 17234302
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Eder T; Köppel H; Wascher TC; Paulweber B; Samonigg H
Breast Cancer Res Treat; 2005 Mar; 90(2):113-5. PubMed ID: 15803357
[TBL] [Abstract][Full Text] [Related]
36. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism (ALA16VAL) correlates with regional lymph node status in breast cancer.
Bica CG; da Silva LL; Toscani NV; Zettler CG; Gottlieb MG; Alexandre CO; Graudenz MS; Mânica da Cruz IB
Cancer Genet Cytogenet; 2010 Jan; 196(2):153-8. PubMed ID: 20082851
[TBL] [Abstract][Full Text] [Related]
38. XPD common variants and their association with melanoma and breast cancer risk.
Debniak T; Scott RJ; Huzarski T; Byrski T; Masojć B; van de Wetering T; Serrano-Fernandez P; Górski B; Cybulski C; Gronwald J; Debniak B; Maleszka R; Kładny J; Bieniek A; Nagay L; Haus O; Grzybowska E; Wandzel P; Niepsuj S; Narod SA; Lubinski J
Breast Cancer Res Treat; 2006 Jul; 98(2):209-15. PubMed ID: 16685590
[TBL] [Abstract][Full Text] [Related]
39. Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?
Jakubowska A; Jaworska K; Cybulski C; Janicka A; Szymańska-Pasternak J; Lener M; Narod SA; Lubiński J;
Eur J Cancer; 2009 Mar; 45(5):837-42. PubMed ID: 19071013
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
